Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Arrowhead Pharma (ARWR)

Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,420,241
  • Shares Outstanding, K 124,434
  • Annual Sales, $ 3,550 K
  • Annual Income, $ -599,490 K
  • EBIT $ -601 M
  • EBITDA $ -586 M
  • 60-Month Beta 0.90
  • Price/Sales 681.57
  • Price/Cash Flow N/A
  • Price/Book 12.65

Options Overview Details

View History
  • Implied Volatility 60.34% ( -1.07%)
  • Historical Volatility 99.11%
  • IV Percentile 38%
  • IV Rank 55.33%
  • IV High 86.91% on 02/29/24
  • IV Low 27.43% on 09/20/24
  • Put/Call Vol Ratio 0.09
  • Today's Volume 787
  • Volume Avg (30-Day) 1,733
  • Put/Call OI Ratio 0.44
  • Today's Open Interest 13,763
  • Open Int (30-Day) 21,360

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.40
  • Number of Estimates 7
  • High Estimate 2.91
  • Low Estimate -1.23
  • Prior Year -1.24
  • Growth Rate Est. (year over year) +67.74%

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.73 +5.45%
on 11/25/24
27.34 -27.76%
on 11/29/24
+1.21 (+6.53%)
since 11/22/24
3-Month
17.05 +15.84%
on 10/10/24
27.34 -27.76%
on 11/29/24
-0.25 (-1.25%)
since 09/23/24
52-Week
17.05 +15.84%
on 10/10/24
39.83 -50.41%
on 01/10/24
-10.60 (-34.93%)
since 12/22/23

Most Recent Stories

More News
Arrowhead, Sarepta Stocks Rise Despite Price-Target Cuts Post $1B Licensing Deal: Retail Buzz Strong

Piper reduced Sarepta’s price target to $182 from $200, highlighting the partnership’s near-term financial impact.

ARWR : 19.75 (+1.54%)
SRPT : 120.66 (+1.42%)
Arrowhead Pharma Stock Soars Pre-Market On $825M Sarepta Licensing Deal: Retail Activity Hits Year-High

The global licensing deal includes $500 million in cash and $325 million in equity, at a 35% premium upon closing.

ARWR : 19.75 (+1.54%)
SRPT : 120.66 (+1.42%)
IJH : 62.52 (+0.26%)
VTI : 294.00 (+0.25%)
Arrowhead Research: Fiscal Q3 Earnings Snapshot

Arrowhead Research: Fiscal Q3 Earnings Snapshot

ARWR : 19.75 (+1.54%)
Arrowhead Research: Fiscal Q2 Earnings Snapshot

Arrowhead Research: Fiscal Q2 Earnings Snapshot

ARWR : 19.75 (+1.54%)
Arrowhead Research: Fiscal Q1 Earnings Snapshot

Arrowhead Research: Fiscal Q1 Earnings Snapshot

ARWR : 19.75 (+1.54%)
Arrowhead Research: Fiscal Q3 Earnings Snapshot

Arrowhead Research: Fiscal Q3 Earnings Snapshot

ARWR : 19.75 (+1.54%)
Arrowhead Research: Fiscal Q2 Earnings Snapshot

Arrowhead Research: Fiscal Q2 Earnings Snapshot

ARWR : 19.75 (+1.54%)
Arrowhead Pharmaceuticals Reports Fiscal 2023 Second Quarter Results

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal second quarter ended March 31, 2023. The company is hosting a conference call today, May 2, 2023, at 4:30...

ARWR : 19.75 (+1.54%)
UPS, Packaging Corp. fall, Arrowhead, Tenet rise

Stocks that traded heavily or had substantial price changes Tuesday: UPS, Packaging Corp. fall, Arrowhead, Tenet rise

THC : 129.64 (+0.14%)
JBLU : 7.68 (+3.23%)
CNC : 60.25 (+1.12%)
ARWR : 19.75 (+1.54%)
UPS : 125.75 (+0.06%)
PEP : 151.29 (-0.98%)
Why Shares of Arrowhead Pharmaceuticals Are Up Tuesday

The clinical-stage biotech announced promising news regarding a potential therapy for inflammatory pulmonary diseases.

AMGN : 264.00 (+0.24%)
GSK : 34.06 (+1.37%)
TAK : 13.17 (+0.53%)
ARWR : 19.75 (+1.54%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company which develops novel drugs to treat intractable diseases primarily in the United States. The company's proprietary Dynamic Polyconjugate platform develops drugs based on the RNA interference mechanism which silences disease-causing genes....

See More

Key Turning Points

3rd Resistance Point 20.62
2nd Resistance Point 20.28
1st Resistance Point 20.02
Last Price 19.75
1st Support Level 19.42
2nd Support Level 19.08
3rd Support Level 18.82

See More

52-Week High 39.83
Fibonacci 61.8% 31.13
Fibonacci 50% 28.44
Fibonacci 38.2% 25.75
Last Price 19.75
52-Week Low 17.05

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar